You are viewing: South Africa Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The South Africa Latent TB Testing Market was valued at $1.26 Million in 2024 and projected to reach to $1.92 Million by 2029, representing a compound annual growth rate of 8.9%. South Africa's latent TB testing market is positioned for sustained growth through 2029, driven by the country's commitment to TB elimination and strengthened public health policies.

South Africa Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Africa Latent TB Testing Market Trends and Insights

  • This 8.9% compound annual growth rate reflects South Africa's heightened focus on tuberculosis screening and prevention, driven by the country's significant TB burden and strengthened healthcare infrastructure.
  • South Africa's market expansion is supported by increased diagnostic adoption, government TB control initiatives, and rising awareness of latent TB infection management among healthcare providers and at-risk populations. The latent TB testing landscape in South Africa is characterized by growing demand for both immunological and molecular diagnostic methods.
  • South Africa's healthcare system has prioritized TB elimination strategies, creating favorable conditions for latent TB testing uptake across public and private sectors.
  • Between 2024 and 2029, South Africa is expected to see accelerated market penetration as testing accessibility improves and clinical guidelines emphasize early detection of latent TB in vulnerable populations, including HIV-positive individuals and healthcare workers..

Key Market Statistics

  • CAGR (2024-2029) 8.9% CAGR
  • Market Size, 2024 ~USD 1.26 Million
  • Forecast, 2029 ~USD 1.92 Million
  • Country South Africa

South Africa Latent TB Testing Market Overview

High TB Burden Drives Testing Demand :

South Africa faces one of the world's highest TB burdens, with latent TB infection affecting millions. This epidemiological reality creates sustained demand for latent TB testing across healthcare facilities, occupational health programs, and public health initiatives.

Rapid Market Expansion :

The South African latent TB testing market is growing at 8.9% CAGR (2024-2029), significantly outpacing the global rate of 5.8%. This accelerated growth reflects increased government investment in TB prevention and screening infrastructure across the country.

Healthcare Infrastructure Strengthening :

South Africa's expanding healthcare infrastructure, including improved laboratory capacity and diagnostic capabilities, supports wider adoption of latent TB testing. Enhanced access to testing in both urban and rural settings drives market penetration.

Market Size and Trajectory :

Valued at USD 1.26 million in 2024, South Africa's latent TB testing market is projected to reach USD 1.92 million by 2029. This 52% growth over five years demonstrates strong market momentum and increasing healthcare spending on TB prevention.

South Africa Latent TB Testing Market Dynamics

  • Government initiatives targeting high-risk populations, including healthcare workers and immunocompromised individuals, continue to expand testing accessibility.
  • The integration of advanced diagnostic technologies and improved laboratory networks across provinces supports market expansion. Future growth will be supported by increased awareness campaigns, occupational health screening mandates, and integration of latent TB testing into routine healthcare protocols.
  • Investment in healthcare infrastructure and diagnostic capacity, coupled with international funding for TB control programs, will further accelerate market development.
  • South Africa's strategic focus on preventive TB care positions the market for continued double-digit growth through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • South Africa's latent TB testing market is valued at USD 1.26 million in 2024, with projected growth to USD 1.92 million by 2029.
    • South Africa demonstrates an 8.9% CAGR, outpacing global growth rates due to heightened TB control priorities and diagnostic infrastructure investment.
    • South Africa's market is driven by government TB elimination initiatives, increased testing in HIV-positive populations, and healthcare worker screening programs.
    • South Africa's latent TB testing adoption is accelerating through improved accessibility, clinical guideline implementation, and public-private sector collaboration.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    South Africa Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    Target Audience

    • Diagnostic Equipment Manufacturers : Need South Africa-specific market data to assess demand for latent TB testing platforms, plan product launches, and identify distribution partnerships within the country's growing healthcare diagnostic sector.
    • Healthcare Facility Operators : Require market insights to justify investment in latent TB testing infrastructure, understand patient demand patterns, and optimize diagnostic service offerings across South African clinics and hospitals.
    • Public Health Authorities : Utilize market analysis to inform TB prevention policy, allocate resources for screening programs, and evaluate the effectiveness of latent TB testing initiatives across South African provinces.
    • Investment and Private Equity Firms : Need comprehensive South Africa market data to evaluate investment opportunities in TB diagnostics, healthcare technology, and preventive care companies operating in the region.
    • Pharmaceutical and Biotech Companies : Require South African market intelligence to assess latent TB treatment demand, plan clinical trial recruitment, and develop market access strategies for TB prevention therapies.

    Reasons to Buy this Report

    • Country-Specific Market Sizing : Obtain precise market valuation for South Africa's latent TB testing sector with verified 2024 baseline (USD 1.26M) and 2029 forecast (USD 1.92M), enabling accurate budget allocation and revenue projections for South African operations.
    • Growth Rate Intelligence : Understand South Africa's 8.9% CAGR—significantly higher than global 5.8%—to identify accelerated expansion opportunities and competitive advantages specific to the South African market landscape.
    • Regional Healthcare Dynamics : Gain insights into South Africa's unique TB burden, healthcare infrastructure development, and government prevention initiatives that directly influence latent TB testing adoption and market trajectory.
    • Strategic Market Entry Planning : Develop targeted go-to-market strategies for South Africa with data-driven understanding of local market conditions, regulatory environment, and healthcare facility distribution across provinces.
    • Competitive Positioning : Benchmark your organization against South African market trends and identify gaps in latent TB testing accessibility, diagnostic capacity, and service delivery to establish competitive differentiation.

    Frequently asked questions

    What is the current size of South Africa's latent TB testing market?

    South Africa's latent TB testing market was valued at USD 1.26 million in 2024 and is expected to grow to USD 1.92 million by 2029.

    What is the projected growth rate for South Africa's latent TB testing market?

    South Africa's latent TB testing market is projected to grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2029.

    What factors are driving growth in South Africa's latent TB testing market?

    South Africa's market growth is driven by government TB control initiatives, increased screening in HIV-positive populations, healthcare worker testing programs, and improved diagnostic accessibility.

    Which testing methods are most prevalent in South Africa's latent TB market?

    South Africa's latent TB testing market utilizes both immunological methods (such as tuberculin skin tests and IGRAs) and molecular diagnostic approaches, with growing adoption of interferon-gamma release assays.

    How does South Africa's latent TB testing market compare to global trends?

    South Africa's 8.9% CAGR significantly exceeds the global average of 5.8%, reflecting the country's elevated TB burden and prioritized investment in diagnostic infrastructure and screening programs.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status